Literature DB >> 14667872

Predictive value of the number of oocytes retrieved at ultrasound-directed follicular aspiration with regard to fertilization rates and pregnancy outcome in intracytoplasmic sperm injection treatment cycles.

Nwora A Melie1, Olutope A Adeniyi, Osaro M Igbineweka, Richard A Ajayi.   

Abstract

OBJECTIVE: To determine the number of oocytes sufficient for satisfactory fertilization and pregnancy rates in intracytoplasmic sperm injection cycles.
DESIGN: A retrospective analysis.
SETTING: A private assisted conception unit. PATIENT(S): Women in whom at least one oocyte was retrieved in consecutive ultrasound-directed follicular aspirations between June 1999 and June 2001. INTERVENTION(S): Standard protocol for pituitary down-regulation and ovarian stimulation. MAIN OUTCOME MEASURE(S): Number of oocytes retrieved, embryos transferred, fertilization, and pregnancy rates. RESULT(S): The numbers of oocytes obtained per cycle were classified into groups A, B, C, and D, consisting of 110, 124, 96, and 122 cycles, with 1-5, 6-10, 11-15, >15 oocytes retrieved from each patient in each group, respectively. The chance of not obtaining a viable oocyte for injection was highest in group A (5.5%). Most fertilization failures occurred in group A (11.8%). Total cleavage failure occurred in the greatest percentage of cycles in group A (3.6%) with a significantly lower mean number of embryos (1.9 +/- 1.7) being transferred. The clinical pregnancy rate was also lowest in group A (7.1%) compared with groups B (25.8%), C (20.8%), and D (23.8%). CONCLUSION(S): Retrieval of between 6 and 10 oocytes per patient and transfer of a maximum of three cleavage-stage embryos results in high pregnancy rates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667872     DOI: 10.1016/s0015-0282(03)02213-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles.

Authors:  Iman Halvaei; Mohammad Ali Khalili; Mohammad Hossein Razi; Stefania A Nottola
Journal:  J Assist Reprod Genet       Date:  2012-05-30       Impact factor: 3.412

2.  Accumulation of oocytes from a few modified natural cycles to improve IVF results: a pilot study.

Authors:  Ermanno Greco; Katarzyna Litwicka; Cristiana Arrivi; Maria Teresa Varricchio; Daniela Zavaglia; Cecilia Mencacci; Maria Giulia Minasi
Journal:  J Assist Reprod Genet       Date:  2013-11       Impact factor: 3.412

3.  Should ICSI be recommended routinely in patients with four or fewer oocytes retrieved?

Authors:  Martha Luna; Catherine Bigelow; Marlena Duke; Jane Ruman; Benjamin Sandler; Lawrence Grunfeld; Alan B Copperman
Journal:  J Assist Reprod Genet       Date:  2011-07-27       Impact factor: 3.412

4.  Total fertilization failure: is it the end of the story?

Authors:  Inci Kahyaoglu; Berfu Demir; Ayten Turkkanı; Ozgur Cınar; Serdar Dilbaz; Berna Dilbaz; Leyla Mollamahmutoglu
Journal:  J Assist Reprod Genet       Date:  2014-06-25       Impact factor: 3.412

5.  Analysis of 232 total fertilization failure cycles during intracytoplasmic sperm injection.

Authors:  Esma Sarikaya; Ozlem Gun Eryilmaz; Ruya Deveer; Muammer Dogan; Leyla Mollamahmutoglu
Journal:  Iran J Reprod Med       Date:  2011

Review 6.  Availability, effectiveness and safety of ART in sub-Saharan Africa: a systematic review.

Authors:  Barend Botha; Delva Shamley; Silke Dyer
Journal:  Hum Reprod Open       Date:  2018-03-26

Review 7.  Assisted reproductive technologies in rhesus macaques.

Authors:  Don P Wolf
Journal:  Reprod Biol Endocrinol       Date:  2004-06-16       Impact factor: 5.211

8.  Unexplained Total Fertilization Failure after Intracytoplasmic Sperm Injection Cycles: A Case-Control Study on Predictive Factors and Retreatment Prognosis.

Authors:  Parisa Mostafaei; Firouzeh Ghaffari; Zahra Zolfaghari; Samira Vesali
Journal:  Int J Fertil Steril       Date:  2022-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.